Zdravljenje bolnikov s karcinozo peritoneja s HIPEC : vloga anesteziologa

Show document
A+ | A- | | SLO | ENG

Title:	Zdravljenje bolnikov s karcinozo peritoneja s HIPEC : vloga anesteziologa
Authors:	ID Novak, Barbka (Author)
Files:	PDF - Presentation file, download (195,95 KB) MD5: 6D2B549AB3B6D1B02EBC1F6F88F001AE PID: 20.500.12556/dirros/f75f9716-ef44-4009-ae2e-e4cdbc6bf97f
Language:	Slovenian
Typology:	1.04 - Professional Article
Organization:	OI - Institute of Oncology
Abstract:	Bolnik s peritonealno karcinozo, zdravljen s sistemsko kemoterapijo, ima slabo napoved in preživetje nekaj mesecev. V zadnjih letih je postala hipertermična intraperitonealna kemoterapija (HIPEC) po popolni kirurški odstranitvi tumorja možen način zdravljenja karcinoze peritoneja, ki znatno podaljša preživetje bolnikov z območno napredovalo obliko več vrst tumorjev. Opisani so perioperativno anesteziološko vodenje bolnikov in značilnosti prvih 11 posegov s HIPEC, opravljenih na Onkološkem inštitutu v Ljubljani v preteklem letu.
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2010
Number of pages:	str. 37-42
Numbering:	Letn. 14, št. 1
PID:	20.500.12556/DiRROS-8776
UDC:	616.38-006.6-08
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-FGAZBBND
COBISS.SI-ID:	967547
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	2747
Downloads:	560
Metadata:
:	Copy citation

Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Onkologija. strokovni časopis za zdravnike
Shortened title:	Onkologija
Publisher:	Onkološki inštitut
ISSN:	1408-1741
COBISS.SI-ID:	65324032

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	Perioperative Management of Patients with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - An Anesthesiologist, s Point of View
Abstract:	The diagnosis of peritoneal carcinomatosis is often associated with poor prognosis and a median survival of a few months, depending on the primary tumor. Hyperthermic intraperitoneal chemotherapy (HIPEC) after complete surgical resection is currently accepted as a therapeutic option for peritoneal carcinomatosis and it considerably prolongs the survival in several tumor types with peritoneal spread. Perioperative anaesthetic management of the patients undergoing such procedure is described and characteristics of the first 11 HIPEC procedures, performed at the Institute of Oncology Ljubljana in 2009, are presented.